Grantham, Mayo, Van Otterloo & Co (GMO)
CPAY icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Corpay CPAY Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio CPAY Stock Details CPAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-105,200
Closed -$26.2M – 814
2022
Q1 		$26.2M Buy
105,200
+6,500
+7% +$1.54M 0.13% 149
2021
Q4 		$22.1M Buy
98,700
+15,900
+19% +$3.8M 0.11% 159
2021
Q3 		$21.6M Buy
82,800
+400
+0.5% +$103K 0.11% 161
2021
Q2 		$21.1M Buy
82,400
+13,016
+19% +$3.6M 0.11% 163
2021
Q1 		$18.6M Buy
69,384
+33,884
+95% +$9.21M 0.1% 160
2020
Q4 		$9.69M Buy
+35,500
New +$9.11M 0.06% 201
2014
Q2 		– Sell
-1,900
Closed -$219K – 562
2014
Q1 		$219K Sell
1,900
-1,735
-48% -$202K ﹤0.01% 546
2013
Q4 		$426K Sell
3,635
-2,412
-40% -$277K ﹤0.01% 574
2013
Q3 		$666K Sell
6,047
-1,400
-19% -$137K ﹤0.01% 505
2013
Q2 		$605K Buy
+7,447
New +$605K ﹤0.01% 519

Other funds holding CPAY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s CPAY Position: Q2 2022 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Corpay (CPAY) in Q2 2022, closing a stake of 105,200 shares — an estimated $26.2M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CPAY in Q2 2013 and held it in 10 quarters. The position peaked at $26.2M in Q1 2022. 540 funds tracked by Wall St. Rank hold CPAY as of Q2 2022.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Corpay position as of Q2 2022 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 105,200 Corpay shares in Q2 2022, an estimated $26.2M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Corpay in Q2 2013 and held it in 10 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Corpay position peaked at $26.2M in Q1 2022.
  • 540 funds tracked by Wall St. Rank held Corpay as of Q2 2022.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2022, filed 12 Aug 2022.